Claritev Revenue 2019-2024 | CTEV

Claritev revenue from 2019 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Claritev Annual Revenue
(Millions of US $)
2024 $931
2023 $962
2022 $1,080
2021 $1,118
2020 $938
2019 $983
2018 $1,041
Claritev Quarterly Revenue
(Millions of US $)
2024-12-31 $232
2024-09-30 $230
2024-06-30 $233
2024-03-31 $235
2023-12-31 $244
2023-09-30 $243
2023-06-30 $238
2023-03-31 $237
2022-12-31 $241
2022-09-30 $250
2022-06-30 $290
2022-03-31 $298
2021-12-31 $298
2021-09-30 $288
2021-06-30 $276
2021-03-31 $255
2020-12-31 $255
2020-09-30 $224
2020-06-30 $207
2020-03-31 $252
2019-12-31
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.450B $0.931B
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.499B 54.56
Hims & Hers Health (HIMS) United States $14.471B 150.35
Tempus AI (TEM) United States $11.278B 0.00
Inspire Medical Systems (INSP) United States $4.503B 70.35
IRhythm Technologies (IRTC) United States $4.501B 0.00
Privia Health (PRVA) United States $3.050B 208.50
Enovis (ENOV) United States $2.060B 11.48
Clover Health Investments (CLOV) United States $1.807B 0.00
Schrodinger (SDGR) United States $1.722B 0.00
Phreesia (PHR) United States $1.510B 0.00
Omnicell (OMCL) United States $1.310B 23.11
Azenta (AZTA) United States $1.258B 58.45
10x Genomics (TXG) United States $1.148B 0.00
Fulgent Genetics (FLGT) United States $0.620B 0.00
Butterfly Network (BFLY) United States $0.581B 0.00
Talkspace (TALK) United States $0.499B 149.00
Veradigm (MDRX) United States $0.455B 0.00
Standard BioTools (LAB) United States $0.410B 0.00
TruBridge (TBRG) United States $0.376B 834.67
Health Catalyst (HCAT) United States $0.283B 0.00
Nyxoah SA (NYXH) Belgium $0.214B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.197B 0.00
EUDA Health Holdings (EUDA) Singapore $0.142B 0.00
Pulmonx (LUNG) United States $0.138B 0.00
American Well (AMWL) United States $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.099B 0.00
CareCloud (CCLD) United States $0.089B 3.39
Outset Medical (OM) United States $0.070B 0.00
111 (YI) China $0.067B 0.00
Retrieve Medical Holdings (RMHI) United States $0.059B 0.00
P3 Health Partners (PIII) United States $0.057B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
Zepp Health (ZEPP) Netherlands $0.042B 0.00
Zhongchao (ZCMD) China $0.032B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.013B 0.00
Precipio (PRPO) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Movano (MOVE) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00